Skip to content
Top Globe News – Lifestyle
Author:
Zymeworks Inc.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
October 24, 2026
Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3
October 23, 2026
Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma
October 19, 2026
Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results
October 15, 2026
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition
September 28, 2026
Zymeworks Completes Acquisition of Theravance Biopharma
September 23, 2026
Zymeworks Announces Participation in Upcoming Investor Conferences
August 11, 2026
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 6, 2026
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
July 16, 2026
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026
1
2
Next Page
→